General Information of This Metabolic Reaction (MR) (ID: MR007433)
Formula
Reactant CYC-202 Product Met-4
Reactant Info Product Info
Metabolic Enzyme Cytochrome P450 3A4 (CYP3A4) DME Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR007428 CYC-202 CYC-202 M1 Oxidation - Oxidationn CYC-202 [1]
MR007429 CYC-202 CYC-202 M2 Oxidation - N-dealkylation CYC-202 [1]
MR007430 CYC-202 CYC-202 M3 Oxidation - Oxidationn CYC-202 [1]
MR007431 CYC-202 CYC-202 M4 Oxidation - N-dealkylation CYC-202 [1]
MR007432 CYC-202 CYC-202 M5 Oxidation - Oxidationn CYC-202 [1]
MR007435 CYC-202 CYC-202 M6 Conjugation - Glucuronidation CYC-202 [1]
MR007436 CYC-202 CYC-202 M7 Unclear CYC-202 [1]
MR007434 CYC-202 PMF30-128 Unclear CYC-202 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR011948 O-Desmethyl atevirdine(MET-9) MET-4 Unclear - Unclear Atevirdine [2]
References
1 Metabolism of the trisubstituted purine cyclin-dependent kinase inhibitor seliciclib (R-roscovitine) in vitro and in vivo. Drug Metab Dispos. 2008 Mar;36(3):561-70.
2 Absorption, distribution, metabolism, and excretion of atevirdine in the rat

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.